0001193125-14-139027.txt : 20140530 0001193125-14-139027.hdr.sgml : 20140530 20140410191943 ACCESSION NUMBER: 0001193125-14-139027 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140410 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aldeyra Therapeutics, Inc. CENTRAL INDEX KEY: 0001341235 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 617-513-9882 MAIL ADDRESS: STREET 1: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 FORMER COMPANY: FORMER CONFORMED NAME: Aldexa Therapeutics, Inc. DATE OF NAME CHANGE: 20130102 FORMER COMPANY: FORMER CONFORMED NAME: Neuron Systems Inc DATE OF NAME CHANGE: 20051012 CORRESP 1 filename1.htm CORRESP

ALDEYRA THERAPEUTICS, INC.

15 NEW ENGLAND EXECUTIVE PARK

BURLINGTON, MA 01803

April 10, 2014

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street N.E.

Washington, D.C. 20549

 

Attention: Jeffrey Reidler

Christina De Rosa

 

Re: Aldeyra Therapeutics, Inc.

Registration Statement on Form S-1

File No. 333-193204

REQUEST FOR ACCELERATION OF EFFECTIVENESS

Dear Mr. Reidler and Ms. De Rosa:

As discussed with the Staff by telephone on April 10, 2014, Aldeyra Therapeutics, Inc. (the “Registrant”) hereby withdraws its prior request for acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-193204), as amended (the “Registration Statement”), set forth in its letter dated April 8, 2014.

Best regards,

ALDEYRA THERAPEUTICS, INC.

/s/ Todd C. Brady, M.D., Ph.D.

Todd C. Brady, M.D., Ph.D.

Chief Executive Officer